Archives: In The News

Persist, Adapt, Resist: Has Cancer Met its Match in Small RNAs?

Why RNAi-Based Oncology Must Move Beyond Single-Target Thinking

Robert Schickel, PhD, CEO and Co-Founder is Interviewed by Danniel Levine and The BIO Report.

Targeting Cancer Survival Genes in Solid Tumors

NUAgo Therapeutics CEO and Co-Founder, Robert Schickel,Ph.D., is featured in Life Science Leader.

NUAgo Therapeutics CEO and Co-Founder joins the Empowered Patient Podcast

NUAgo Therapeutics CEO and Co-Founder participates in the World Economic Forum 2026.

Discovery of cancer ‘kill code’ could inspire new treatments

Cancer ‘Super Assassin’: Huntington’s Disease Molecule Can Target and Kill All Tumor Cells, Scientists Find